The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
Open accessAbstract
According to the traditional view, atherosclerosis results from a passive buildup of cholesterol in the artery wall. Yet, burgeoning evidence implicates inflammation and immune effector mechanisms in the pathogenesis of this disease. Both innate and adaptive immunity operate during atherogenesis and link many traditional risk factors to altered arterial functions. Inflammatory pathways have become targets in the quest for novel preventive and therapeutic strategies against cardiovascular disease, a growing contributor to morbidity and mortality worldwide. Here we review current experimental and clinical knowledge of the pathogenesis of atherosclerosis through an immunological lens and how host defense mechanisms essential for survival of the species actually contribute to this chronic disease but also present new opportunities for its mitigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · cited 1×
“Cardiovascular disease (CVD) has become the most frequent cause of death globally (Murray et al., 2012).”
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citationNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 2×
“Genetic targeting of either IL-1b or a component in the NLRP3 inflammasome reduces atherosclerosis in mice, supporting a pathogenic role for this pathway of inflammatory activation (Duewell et al., 2010).”
BackgroundProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Self-citationInflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Self-citationRosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Self-citationGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J.-L., Kohler, R. H., Chudnovskiy, A., Waterman, P., et al. (2009) · Science · doi:10.1126/science.1175202 · Cited by 2,221
Self-citationAtherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
Jonasson, L., Holm, J., Skalli, O., Bondjers, G., & Hansson, G. K. (1986) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.6.2.131 · Cited by 1,335
Self-citationTacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28549 · Cited by 1,323
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Libby, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1216063 · Cited by 1,262
Self-citationC-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150
Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., & Pittet, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29950 · Cited by 1,148
Self-citationNatural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
Self-citationMyocardial infarction accelerates atherosclerosis
Dutta, P., Courties, G., Wei, Y., Leuschner, F., Gorbatov, R., Robbins, C. S., Iwamoto, Y., Thompson, B., Carlson, A. L., Heidt, T., et al. (2012) · Nature · doi:10.1038/nature11260 · Cited by 1,079
Self-citationRajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019
Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60447-5 · Cited by 1,010 · cited 1×
“The use of CRP provided clinical validation of the concept, which emerged from laboratory investigations that statins exhibit direct anti-inflammatory effects, independent of their LDL-lowering properties (Ridker et al., 2009).”
BackgroundSelf-citationFrostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Self-citationT lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943
Self-citationIFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Protective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 831
(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823 · cited 1×
“In particular, recent genetic studies provide robust data linking the IL-6 receptor to coronary heart disease (Sarwar et al., 2012).”
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Self-citationThe multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Weber, C., Zernecke, A., & Libby, P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2415 · Cited by 776
Self-citationBinder, C. J., Hörkkö, S., Dewan, A., Chang, M.-K., Kieu, E. P., Goodyear, C. S., Shaw, P. X., Palinski, W., Witztum, J. L., & Silverman, G. J. (2003) · Nature Medicine · doi:10.1038/nm876 · Cited by 737
Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis
Drechsler, M., Megens, R. T. A., van Zandvoort, M., Weber, C., & Soehnlein, O. (2010) · Circulation · doi:10.1161/circulationaha.110.961714 · Cited by 698
Miller, Y. I., Choi, S.-H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., Boullier, A., Gonen, A., Diehl, C. J., Que, X., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.223875 · Cited by 646
Distribution of macrophage polarization markers in human atherosclerosis
Stöger, J. L., Gijbels, M. J. J., van der Velden, S., Manca, M., van der Loos, C. M., Biessen, E. A. L., Daemen, M. J. A. P., Lutgens, E., & de Winther, M. P. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.013 · Cited by 621
Amento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609
Self-citationPalinski, W., Miller, E., & Witztum, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.821 · Cited by 590
Monocyte-Endothelial Cell Interactions in the Development of Atherosclerosis
Mestas, J., & Ley, K. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.11.004 · Cited by 548
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice
Caligiuri, G., Nicoletti, A., Poirier, B., & Hansson, G. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci7272 · Cited by 530
Self-citationInterferon-γ, a Th1 Cytokine, Regulates Fat Inflammation: A Role for Adaptive Immunity in Obesity
Rocha, V. Z., Folco, E. J., Sukhova, G., Shimizu, K., Gotsman, I., Vernon, A. H., & Libby, P. (2008) · Circulation Research · doi:10.1161/circresaha.108.177105 · Cited by 523
Self-citationSerruys, P. W., García-García, H. M., Buszman, P., Erne, P., Verheye, S., Aschermann, M., Duckers, H., Bleie, O., Dudek, D., Bøtker, H. E., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.771899 · Cited by 505
Extramedullary Hematopoiesis Generates Ly-6C high Monocytes That Infiltrate Atherosclerotic Lesions
Robbins, C. S., Chudnovskiy, A., Rauch, P. J., Figueiredo, J.-L., Iwamoto, Y., Gorbatov, R., Etzrodt, M., Weber, G. F., Ueno, T., van Rooijen, N., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.061986 · Cited by 482
Self-citationB cell depletion reduces the development of atherosclerosis in mice
Ait-Oufella, H., Herbin, O., Bouaziz, J.-D., Binder, C. J., Uyttenhove, C., Laurans, L., Taleb, S., Van Vré, E., Esposito, B., Vilar, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100155 · Cited by 469
Quehenberger, O., & Dennis, E. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1104901 · Cited by 454
Disruption of TGF-β signaling in T cells accelerates atherosclerosis
Robertson, A.-K. L., Rudling, M., Zhou, X., Gorelik, L., Flavell, R. A., & Hansson, G. K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18607 · Cited by 441
Self-citationSPLENECTOMY AND SUBSEQUENT MORTALITY IN VETERANS OF THE 1939-45 WAR
Dennis Robinette, C., & Fraumeni, J. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90132-5 · Cited by 427
Bae, Y. S., Lee, J. H., Choi, S. H., Kim, S., Almazan, F., Witztum, J. L., & Miller, Y. I. (2009) · Circulation Research · doi:10.1161/circresaha.108.181040 · Cited by 427
Mast cells promote atherosclerosis by releasing proinflammatory cytokines
Sun, J., Sukhova, G. K., Wolters, P. J., Yang, M., Kitamoto, S., Libby, P., MacFarlane, L. A., Clair, J. M.-S., & Shi, G.-P. (2007) · Nature Medicine · doi:10.1038/nm1601 · Cited by 425
Self-citationBlockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice
Smith, E., Prasad, K.-M. R., Butcher, M., Dobrian, A., Kolls, J. K., Ley, K., & Galkina, E. (2010) · Circulation · doi:10.1161/circulationaha.109.924886 · Cited by 421
Eid, R. E., Rao, D. A., Zhou, J., Lo, S.-F. L., Ranjbaran, H., Gallo, A., Sokol, S. I., Pfau, S., Pober, J. S., & Tellides, G. (2009) · Circulation · doi:10.1161/circulationaha.108.827618 · Cited by 412
Xu, Q., Dietrich, H., Steiner, H. J., Gown, A. M., Schoel, B., Mikuz, G., Kaufmann, S. H., & Wick, G. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.7.789 · Cited by 388
Wilensky, R. L., Shi, Y., Mohler, E. R., Hamamdzic, D., Burgert, M. E., Li, J., Postle, A., Fenning, R. S., Bollinger, J. G., Hoffman, B. E., et al. (2008) · Nature Medicine · doi:10.1038/nm.1870 · Cited by 387
Exogenous Interferon-γ Enhances Atherosclerosis in Apolipoprotein E−/− Mice
Whitman, S. C., Ravisankar, P., Elam, H., & Daugherty, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64820-1 · Cited by 378
Clinton, S. K., Underwood, R., Hayes, L., Sherman, M. L., Kufe, D. W., & Libby, P. (1992) · PubMed · Cited by 377
Self-citationSalomon, R., Hughes, C. C. W., Schöen, F. J., Payne, D. D., Pober, J. S., & Libby, P. (1991) · PubMed · Cited by 372
Self-citationEverett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.018 · Cited by 368 · cited 4×
“In addition, inflammasome activation by cholesterol crystals within plaques provides a stimulus to local production of active IL-1b, providing additional rationale for this therapeutic intervention.”
BackgroundInfluentialSelf-citationDepletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis
Klingenberg, R., Gerdes, N., Badeau, R. M., Gisterå, A., Strodthoff, D., Ketelhuth, D. F. J., Lundberg, A. M., Rudling, M., Nilsson, S. K., Olivecrona, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63891 · Cited by 367
Self-citationvan Gils, J. M., Derby, M. C., Fernandes, L. R., Ramkhelawon, B., Ray, T. D., Rayner, K. J., Parathath, S., Distel, E., Feig, J. L., Alvarez-Leite, J. I., et al. (2012) · Nature Immunology · doi:10.1038/ni.2205 · Cited by 365
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
Sen-Banerjee, S., Mir, S., Lin, Z., Hamik, A., Atkins, G. B., Das, H., Banerjee, P., Kumar, A., & Jain, M. K. (2005) · Circulation · doi:10.1161/circulationaha.104.525774 · Cited by 354
Rook, G. A. W. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04133.x · Cited by 332
CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis
Tupin, E., Nicoletti, A., Elhage, R., Rudling, M., Ljunggren, H.-G., Hansson, G. K., & Berne, G. P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030997 · Cited by 329
Self-citationLutgens, E., Gijbels, M., Smook, M., Heeringa, P., Gotwals, P., Koteliansky, V. E., & Daemen, M. J. A. P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000019729.39500.2f · Cited by 313
Jonasson, L., Holm, J., Skalli, O., Gabbiani, G., & Hansson, G. K. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111934 · Cited by 311
Self-citationArginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells
Raes, G., Van den Bergh, R., De Baetselier, P., & Ghassabeh, G. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6561 · Cited by 302
Intertwining of thrombosis and inflammation in atherosclerosis
Croce, K., & Libby, P. (2007) · Current Opinion in Hematology · doi:10.1097/00062752-200701000-00011 · Cited by 284
Self-citationBot, I., de Jager, S. C. A., Zernecke, A., Lindstedt, K. A., van Berkel, T. J. C., Weber, C., & Biessen, E. A. L. (2007) · Circulation · doi:10.1161/circulationaha.106.660472 · Cited by 282
Presence of luminal neutrophil extracellular traps in atherosclerosis
Megens, R. T. A., Vijayan, S., Lievens, D., Döring, Y., van Zandvoort, M. A. M. J., Grommes, J., Weber, C., & Soehnlein, O. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-09-0650 · Cited by 276
Nagano, H., Mitchell, R. N., Taylor, M. K., Hasegawa, S., Tilney, N. L., & Libby, P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119564 · Cited by 275
Self-citationHundelshausen, P. V., & Lievens, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0592 · Cited by 271
Maron, R., Sukhova, G., Faria, A.-M., Hoffmann, E., Mach, F., Libby, P., & Weiner, H. L. (2002) · Circulation · doi:10.1161/01.cir.0000029750.99462.30 · Cited by 267
Self-citationRegulation of Hematopoietic Stem and Progenitor Cell Mobilization by Cholesterol Efflux Pathways
Westerterp, M., Gourion-Arsiquaud, S., Murphy, A. J., Shih, A., Cremers, S., Levine, R. L., Tall, A. R., & Yvan-Charvet, L. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.024 · Cited by 260
Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
Hermansson, A., Ketelhuth, D. F. J., Strodthoff, D., Wurm, M., Hansson, E. M., Nicoletti, A., Paulsson-Berne, G., & Hansson, G. K. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092243 · Cited by 240
Self-citationUnusual CD4+CD28nullT Lymphocytes and Recurrence of Acute Coronary Events
Liuzzo, G., Biasucci, L. M., Trotta, G., Brugaletta, S., Pinnelli, M., Digianuario, G., Rizzello, V., Rebuzzi, A. G., Rumi, C., Maseri, A., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.040 · Cited by 238
Mechanisms for the anti-inflammatory effects of statins
Bu, D.-X., Griffin, G., & Lichtman, A. H. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283453e41 · Cited by 234
Self-citationB‐cell targeted therapies in human autoimmune diseases: an updated perspective
Townsend, M. J., Monroe, J. G., & Chan, A. C. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00945.x · Cited by 232
Scirica, B. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.071 · Cited by 227
Emerging role of Toll-like receptors in atherosclerosis
Curtiss, L. K., & Tobias, P. S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800056-jlr200 · Cited by 225 · cited 1×
“Several experiments that use gene-targeted mice have addressed the role of TLRs in atherogenesis, yielding rather complex results (Curtiss and Tobias, 2009).”
Mullick, A. E., Soldau, K., Kiosses, W. B., Bell, T. A., Tobias, P. S., & Curtiss, L. K. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071096 · Cited by 223
The role of adaptive T cell immunity in atherosclerosis
Mallat, Z., Taleb, S., Ait-Oufella, H., & Tedgui, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800092-jlr200 · Cited by 222
Gotsman, I., Grabie, N., Gupta, R., Dacosta, R., MacConmara, M., Lederer, J., Sukhova, G., Witztum, J. L., Sharpe, A. H., & Lichtman, A. H. (2006) · Circulation · doi:10.1161/circulationaha.106.633263 · Cited by 215
Self-citationHeat Shock Protein 60 Activates B Cells via the TLR4-MyD88 Pathway
Cohen-Sfady, M., Nussbaum, G., Pevsner-Fischer, M., Mor, F., Carmi, P., Zanin-Zhorov, A., Lider, O., & Cohen, I. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3594 · Cited by 213
Klingenberg, R., Lebens, M., Hermansson, A., Fredrikson, G. N., Strodthoff, D., Rudling, M., Ketelhuth, D. F. J., Gerdes, N., Holmgren, J., Nilsson, J., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.202671 · Cited by 201
Self-citationTh2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas
Shimizu, K., Shichiri, M., Libby, P., Lee, R. T., & Mitchell, R. N. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19855 · Cited by 200
Self-citationTardif, J.-C., McMurray, J. J., Klug, E., Small, R., Schumi, J., Choi, J., Cooper, J., Scott, R., Lewis, E. F., L'Allier, P. L., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60763-1 · Cited by 199
Adaptive immunity in atherogenesis: new insights and therapeutic approaches
Lichtman, A. H., Binder, C. J., Tsimikas, S., & Witztum, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63108 · Cited by 198
Self-citationHermansson, A., Johansson, D. K., Ketelhuth, D. F. J., Andersson, J., Zhou, X., & Hansson, G. K. (2011) · Circulation · doi:10.1161/circulationaha.110.973222 · Cited by 189
Self-citationMacrophage heterogeneity in atherosclerotic plaques
Johnson, J. L., & Newby, A. C. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283309848 · Cited by 183
Kyaw, T., Tay, C., Hosseini, H., Kanellakis, P., Gadowski, T., MacKay, F., Tipping, P., Bobik, A., & Toh, B.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029371 · Cited by 183
Cholesterol and atherosclerosis
Libby, P. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00161-x · Cited by 175
Self-citationTh2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas
Shimizu, K., Shichiri, M., Libby, P., Lee, R. T., & Mitchell, R. N. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419855 · Cited by 172
Self-citationCrystallization of Free Cholesterol in Model Macrophage Foam Cells
Kellner-Weibel, G., Yancey, P. G., Jerome, W. G., Walser, T., Mason, R. P., Phillips, M. C., & Rothblat, G. H. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.1891 · Cited by 170
Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs
Subramanian, M., Thorp, E., Hansson, G. K., & Tabas, I. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64617 · Cited by 164
Self-citationBuono, C., Pang, H. B., Uchida, Y., Libby, P., Sharpe, A. H., & Lichtman, A. H. (2004) · Circulation · doi:10.1161/01.cir.0000127121.16815.f1 · Cited by 160
Self-citationSeifert, P. S., Hugo, F., Hansson, G. K., & Bhakdi, S. (1989) · PubMed · Cited by 159
Self-citationParticipation of blood vessel cells in human adaptive immune responses
Pober, J. S., & Tellides, G. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.09.006 · Cited by 156
BAFF Receptor Deficiency Reduces the Development of Atherosclerosis in Mice—Brief Report
Sage, A. P., Tsiantoulas, D., Baker, L. L., Harrison, J. E., Masters, L. M., Murphy, D., Loinard, C., Binder, C. J., & Mallat, Z. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244731 · Cited by 154
Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans
Gerdes, N., Zhu, L., Ersoy, M., Hermansson, A., Hjemdahl, P., Hu, H., Hansson, G. K., & Li, N. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-01-0020 · Cited by 145
Self-citationThe role of innate immunity in atherogenesis
Hartvigsen, K., Chou, M.-Y., Hansen, L. F., Shaw, P. X., Tsimikas, S., Binder, C. J., & Witztum, J. L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800100-jlr200 · Cited by 145
Mast cells: multipotent local effector cells in atherothrombosis
Kovanen, P. T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00515.x · Cited by 145
CD1 Expression in Human Atherosclerosis
Melián, A., Geng, Y., Sukhova, G. K., Libby, P., & Porcelli, S. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65176-0 · Cited by 139
Self-citationMolecular Imaging of Atherosclerosis for Improving Diagnostic and Therapeutic Development
Quillard, T., & Libby, P. (2012) · Circulation Research · doi:10.1161/circresaha.112.268144 · Cited by 136
Self-citationKyaw, T. S., Cui, P., Tay, C., Kanellakis, P., Hosseini, H., Liu, E., Rolink, A. G., Tipping, P. G., Bobik, A., & Toh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060430 · Cited by 129
Packard, R. R. S., Maganto-García, E., Gotsman, I., Tabas, I. A., Libby, P., & Lichtman, A. H. (2008) · Circulation Research · doi:10.1161/circresaha.108.185793 · Cited by 125
Self-citationWhite, H. D., Held, C., Stewart, R., Watson, D. I., Harrington, R. A., Budaj, A., Steg, P. G., Cannon, C. P., Krug‐Gourley, S., Wittes, J. T., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.07.006 · Cited by 125
The Discovery of Cellular Immunity in the Atherosclerotic Plaque
Hansson, G. K., & Jonasson, L. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179713 · Cited by 122
Self-citationDumitriu, I. E., Baruah, P., Finlayson, C. J., Loftus, I. M., Antunes, R. D. S., Lim, P. O., Bunce, N. H., & Kaski, J. C. (2012) · Circulation Research · doi:10.1161/circresaha.111.261933 · Cited by 121
CD137 (4–1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
Jeon, H. J., Choi, J., Jung, I., Park, J., Lee, M., Lee, M.-N., Kim, B., Yoo, J. Y., Jeong, S., Kim, D.-Y., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.882704 · Cited by 120
Salagianni, M. L., Galani, I. E., Lundberg, A. M., Davos, C. H., Varela, A., Gavriil, A., Lyytikäinen, L., Lehtimäki, T. J., Sigala, F., Folkersen, L., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.067678 · Cited by 113
Self-citationSequestration of aggregated low-density lipoproteins by macrophages
Kruth, H. S. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00003 · Cited by 111
Regulatory T‐cell immunity and its relevance to atherosclerosis
Taleb, S., Tedgui, A., & Mallat, Z. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01944.x · Cited by 107
Dendritic cells and their role in atherogenesis
Bobryshev, Y. V. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.94 · Cited by 102
IFN-γ action in the media of the great elastic arteries, a novel immunoprivileged site
Canto, A. J. D., Swanson, P. E., O'Guin, A. K., Speck, S. H., & Virgin, H. W. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11540 · Cited by 97
Cuffy, M. C., Silverio, A. M., Qin, L., Wang, Y., Eid, R. E., Brandacher, G., Lakkis, F. G., Fuchs, D., Pober, J. S., & Tellides, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5246 · Cited by 96
O’Donoghue, M. L., D, E. B. M., White, H. D., Serruys, P. W. J. C., Steg, P. G., Hochman, J. S., Maggioni, A. P., Bode, C., Weaver, D., Johnson, J. L., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.07.018 · Cited by 90
Sol Sherry Lecture in Thrombosis: Molecular Events in Acute Inflammation
Prescott, S. M., McIntyre, T. M., Zimmerman, G. A., & Stafforini, D. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000016153.47693.b2 · Cited by 75
Inhibition of IL-17A in atherosclerosis
Cheng, X. C., Taleb, S., Wang, J., Tang, T., Chen, J., Gao, X., Yao, R., Xie, J.-J., Yu, X., Xia, N., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.12.034 · Cited by 71
Murray, A. G., Libby, P., & Pober, J. S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.151 · Cited by 70
Self-citationVanderLaan, P. A., Reardon, C. A., Sagiv, Y., Blachowicz, L., Lukens, J. R., Nissenbaum, M., Wang, C.-R., & Getz, G. S. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060188 · Cited by 68
Resident intimal dendritic cells and the initiation of atherosclerosis
Cybulsky, M. I., & Jongstra‐Bilen, J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833ded96 · Cited by 67
Sakash, J. B., Byrne, G. I., Lichtman, A. H., & Libby, P. (2002) · Infection and Immunity · doi:10.1128/iai.70.7.3959-3961.2002 · Cited by 66
Self-citationLewis, R. D., Jackson, C. L., Morgan, B. P., & Hughes, T. R. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.10.035 · Cited by 63
Wigren, M., Bengtsson, D., Dunér, P., Olofsson, K., Björkbacka, H., Bengtsson, E., Fredrikson, G. N., & Nilsson, J. Å. (2009) · Circulation Research · doi:10.1161/circresaha.109.196667 · Cited by 61
Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease
Amir, S., Hartvigsen, K., Gonen, A., Leibundgut, G., Que, X., Jensen‐Jarolim, E., Wagner, O. F., Tsimikas, S., Witztum, J. L., & Binder, C. J. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m025445 · Cited by 57
Wennberg, P., Wensley, F., Angelantonio, E. D., Johansson, L., Boman, K., Rumley, A., Lowe, G. D. O., Hallmans, G., Danesh, J., & Jansson, J. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.05.015 · Cited by 53
Devalapalli, A. P., Lesher, A. P., Shieh, K., Solow, J. S., Everett, M. L., Edala, A. S., Whitt, P. B., Long, R. R., Newton, N. H., & Parker, W. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01785.x · Cited by 53
The fate of lipoprotein cholesterol entering the arterial wall
Kruth, H. S. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00002 · Cited by 53
Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe/ mice
Klingenberg, R., Ketelhuth, D. F. J., Strodthoff, D., Gregori, S., & Hansson, G. K. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.06.006 · Cited by 52
Self-citationNatural Antibodies in Murine Atherosclerosis
Witztum, J. L., Binder, C. J., Chou, M.-Y., Fogelstrand, L., Hartvigsen, K., Shaw, P. X., & Boullier, A. (2008) · Current Drug Targets · doi:10.2174/138945008783755520 · Cited by 46
Nicholls, S. J., Cavender, M. A., Kastelein, J. J. P., Schwartz, G. G., Waters, D. D., Rosenson, R. S., Bash, D., & Hislop, C. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6358-9 · Cited by 44
Complement and atherosclerosis—united to the point of no return?
Torzewski, M., & Bhakdi, S. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.012 · Cited by 39
Vaccines against atherosclerosis
Nilsson, J. Å., Wigren, M., & Shah, P. K. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.4 · Cited by 37
A functional role for inducible costimulator (ICOS) in atherosclerosis
Afek, A. B., Harats, D., Roth, A., Keren, G., & George, J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.040 · Cited by 34
The Ins and Outs of Inflammatory Cells in Atheromata
Świrski, F. K., Nahrendorf, M., & Libby, P. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.012 · Cited by 29
Self-citationZhang, P., Manes, T. D., Pober, J. S., & Tellides, G. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200758 · Cited by 24
Nussenblatt, R. B., Bielekova, B., Childs, R. W., Krensky, A. M., Strober, W., & Trinchieri, G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05682.x · Cited by 14
Vascular Dendritic Cells as Gatekeepers of Lipid Accumulation Within Nascent Atherosclerotic Plaques
Randolph, G. J., & Potteaux, S. (2010) · Circulation Research · doi:10.1161/circresaha.109.212191 · Cited by 8
Interleukin-17 and Atherosclerotic Vascular Disease
Pober, J. S. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228338 · Cited by 8
Cited by
Libby, P., Buring, J. E., Badimon, L., Hansson, G. K., Deanfield, J., Bittencourt, M. S., Tokgözoğlu, L., & Lewis, E. F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0106-z · Cited by 3,211
Self-citationCholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
The Sleep-Immune Crosstalk in Health and Disease
Besedovsky, L., Lange, T., & Haack, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00010.2018 · Cited by 1,479
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Inflammation and plaque vulnerability
Hansson, G. K., Libby, P., & Tabas, I. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 805
Self-citation
Metadata
- Authors
- Libby, P., Lichtman, A. H., & Hansson, G. K.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 38
- Issue
- 6
- Pages
- 1092-1104
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2060034277
- Cited by
- 671
- References
- 136
- FWCI
- 38.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.